Deep Brain Stimulation In Parkinson’s Disease Market, By Product, By End-use, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
Description
REPORT HIGHLIGHT
Deep Brain Stimulation In Parkinson’s Disease Market size was valued at US$ 910.28 Million in 2024, expanding at a CAGR of 10.30% from 2025 to 2032.
Deep Brain Stimulation (DBS) in Parkinson’s Disease market refers to the global industry that focuses on devices, technologies, and services for treating Parkinson's disease with deep brain stimulation therapy. DBS is the surgical implantation of electrodes in specific areas of the brain to deliver controlled electrical impulses, which help manage motor symptoms such as tremors, stiffness, and bradykinesia that are not adequately controlled by medication. This market consists of implantable pulse generators (IPGs), electrodes, stimulation programming software, and post-implantation support services.
Deep Brain Stimulation In Parkinson’s Disease Market- Market Dynamics
Rising prevalence of neurological disorders fuels market growth
The growing prevalence of neurological disorders is expected to drive the Deep Brain Stimulation In Parkinson's Disease Market in the coming years. Neurological disorders are a diverse group of diseases that affect the autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to deliver electrical stimulation to the target area, with the goal of altering or modulating neural functioning and achieving a reversible, adjustable, and therapeutic effect. For instance, the Parkinson's Foundation, a US-based national organization, estimates that nearly 90,000 people were diagnosed with Parkinson's disease in the United States in March 2023, a 50% increase from the previously estimated rate of 60,000 diagnoses per year. As a result, the growing prevalence of neurological disorders is driving the growth of the Deep Brain Stimulation in Parkinson's Disease market.
Deep Brain Stimulation In Parkinson’s Disease Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.30% over the forecast period (2025-2032)
Based on Product segmentation, Dual-channel is predicted to show maximum market share in the year 2025
Based on End-use segmentation, hospital is the leading End-use in 2025
On the basis of region, North America is the leading revenue generator in 2025
Deep Brain Stimulation In Parkinson’s Disease Market- Segmentation Analysis:
The Global Deep Brain Stimulation In Parkinson’s Disease Market is segmented on the basis of Product, End-use, and Region.
The market is divided into two categories based on Product: Single-channel, and Dual-channel. The dual-channel segment will account for the largest share in 2025 due to its superior effectiveness in reducing patient tremors and improving overall quality of life. Dual-channel DBS devices provide greater control and precision in delivering electrical stimulation to specific brain regions, making them popular among neurosurgeons and patients alike. Dual-channel systems' robust performance and reliability have cemented their market leadership.
The market is divided into four categories based on End-use: Hospitals, Ambulatory Surgical Centers, Neurology Clinics, and Research Centers. The hospital segment will dominate the market in 2025. Hospitals are frequently equipped with advanced medical technology and specialized personnel, allowing them to provide comprehensive care to patients requiring DBS therapy. Many patients prefer hospitals because of the procedure's complexity and the need for continuous monitoring and support throughout the treatment process. Furthermore, hospitals typically provide a multidisciplinary approach that includes neurologists, neurosurgeons, and other healthcare professionals, improving patient outcomes through coordinated care. Because Parkinson's disease frequently presents with a variety of symptoms that necessitate ongoing management, hospitals are well-positioned to provide the comprehensive care required for effective treatment.
Deep Brain Stimulation In Parkinson’s Disease Market- Geographical Insights
North America Deep Brain Stimulation will have the largest revenue share in the Parkinson's disease market in 2025. The region's dominance can be attributed to a variety of factors, including a high prevalence of Parkinson's disease, advanced healthcare infrastructure, and substantial government and private funding for research and development. Technological advancements, such as robot-assisted implantation and improved microelectrode designs, have boosted market growth in this region.
The Asia Pacific Deep Brain Stimulation In Parkinson's Disease Market is expected to grow the fastest over the forecast period. This rapid growth can be attributed to the rising prevalence of Parkinson's disease, rising healthcare costs, and increased awareness of DBS treatment. The region is also benefiting from technological advancements and the introduction of new DBS devices. Governments in the Asia Pacific region are actively encouraging the use of DBS therapy by providing favorable policies and funding for R&D.
Deep Brain Stimulation In Parkinson’s Disease Market- Competitive Landscape:
Several major medical device companies drive innovation and market growth in the DBS market through research and development. Leading players improve their products and differentiate themselves with advanced technologies and patient-centric solutions. Several major players dominate the market, which is moderately consolidated. However, new companies and startups are increasing competition and technological advancements, improving DBS systems and patient outcomes. Medtronic, Boston Scientific, and Abbott are DBS market leaders with extensive neurostimulation device portfolios and global presence. One of the largest DBS manufacturers, Medtronic, offers systems with adaptive stimulation and MRI compatibility. Innovation and collaboration with research institutions have kept the company competitive. Boston Scientific, another major player, develops cutting-edge DBS therapy technologies to meet diverse patient needs.
Recent Developments:
In August 2024, Medtronic plc has received FDA approval for Asleep DBS surgery for Parkinson's and essential tremor patients. This novel approach allows patients to have DBS surgery while awake or asleep, increasing flexibility and comfort.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Abbott
Boston Scientific Corporation
Medtronic
Others
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
Single-channel
Dual-channel
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
Hospitals
Ambulatory Surgical Centers
Neurology Clinics
Research Centers
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA
Deep Brain Stimulation In Parkinson’s Disease Market size was valued at US$ 910.28 Million in 2024, expanding at a CAGR of 10.30% from 2025 to 2032.
Deep Brain Stimulation (DBS) in Parkinson’s Disease market refers to the global industry that focuses on devices, technologies, and services for treating Parkinson's disease with deep brain stimulation therapy. DBS is the surgical implantation of electrodes in specific areas of the brain to deliver controlled electrical impulses, which help manage motor symptoms such as tremors, stiffness, and bradykinesia that are not adequately controlled by medication. This market consists of implantable pulse generators (IPGs), electrodes, stimulation programming software, and post-implantation support services.
Deep Brain Stimulation In Parkinson’s Disease Market- Market Dynamics
Rising prevalence of neurological disorders fuels market growth
The growing prevalence of neurological disorders is expected to drive the Deep Brain Stimulation In Parkinson's Disease Market in the coming years. Neurological disorders are a diverse group of diseases that affect the autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to deliver electrical stimulation to the target area, with the goal of altering or modulating neural functioning and achieving a reversible, adjustable, and therapeutic effect. For instance, the Parkinson's Foundation, a US-based national organization, estimates that nearly 90,000 people were diagnosed with Parkinson's disease in the United States in March 2023, a 50% increase from the previously estimated rate of 60,000 diagnoses per year. As a result, the growing prevalence of neurological disorders is driving the growth of the Deep Brain Stimulation in Parkinson's Disease market.
Deep Brain Stimulation In Parkinson’s Disease Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.30% over the forecast period (2025-2032)
Based on Product segmentation, Dual-channel is predicted to show maximum market share in the year 2025
Based on End-use segmentation, hospital is the leading End-use in 2025
On the basis of region, North America is the leading revenue generator in 2025
Deep Brain Stimulation In Parkinson’s Disease Market- Segmentation Analysis:
The Global Deep Brain Stimulation In Parkinson’s Disease Market is segmented on the basis of Product, End-use, and Region.
The market is divided into two categories based on Product: Single-channel, and Dual-channel. The dual-channel segment will account for the largest share in 2025 due to its superior effectiveness in reducing patient tremors and improving overall quality of life. Dual-channel DBS devices provide greater control and precision in delivering electrical stimulation to specific brain regions, making them popular among neurosurgeons and patients alike. Dual-channel systems' robust performance and reliability have cemented their market leadership.
The market is divided into four categories based on End-use: Hospitals, Ambulatory Surgical Centers, Neurology Clinics, and Research Centers. The hospital segment will dominate the market in 2025. Hospitals are frequently equipped with advanced medical technology and specialized personnel, allowing them to provide comprehensive care to patients requiring DBS therapy. Many patients prefer hospitals because of the procedure's complexity and the need for continuous monitoring and support throughout the treatment process. Furthermore, hospitals typically provide a multidisciplinary approach that includes neurologists, neurosurgeons, and other healthcare professionals, improving patient outcomes through coordinated care. Because Parkinson's disease frequently presents with a variety of symptoms that necessitate ongoing management, hospitals are well-positioned to provide the comprehensive care required for effective treatment.
Deep Brain Stimulation In Parkinson’s Disease Market- Geographical Insights
North America Deep Brain Stimulation will have the largest revenue share in the Parkinson's disease market in 2025. The region's dominance can be attributed to a variety of factors, including a high prevalence of Parkinson's disease, advanced healthcare infrastructure, and substantial government and private funding for research and development. Technological advancements, such as robot-assisted implantation and improved microelectrode designs, have boosted market growth in this region.
The Asia Pacific Deep Brain Stimulation In Parkinson's Disease Market is expected to grow the fastest over the forecast period. This rapid growth can be attributed to the rising prevalence of Parkinson's disease, rising healthcare costs, and increased awareness of DBS treatment. The region is also benefiting from technological advancements and the introduction of new DBS devices. Governments in the Asia Pacific region are actively encouraging the use of DBS therapy by providing favorable policies and funding for R&D.
Deep Brain Stimulation In Parkinson’s Disease Market- Competitive Landscape:
Several major medical device companies drive innovation and market growth in the DBS market through research and development. Leading players improve their products and differentiate themselves with advanced technologies and patient-centric solutions. Several major players dominate the market, which is moderately consolidated. However, new companies and startups are increasing competition and technological advancements, improving DBS systems and patient outcomes. Medtronic, Boston Scientific, and Abbott are DBS market leaders with extensive neurostimulation device portfolios and global presence. One of the largest DBS manufacturers, Medtronic, offers systems with adaptive stimulation and MRI compatibility. Innovation and collaboration with research institutions have kept the company competitive. Boston Scientific, another major player, develops cutting-edge DBS therapy technologies to meet diverse patient needs.
Recent Developments:
In August 2024, Medtronic plc has received FDA approval for Asleep DBS surgery for Parkinson's and essential tremor patients. This novel approach allows patients to have DBS surgery while awake or asleep, increasing flexibility and comfort.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Abbott
Boston Scientific Corporation
Medtronic
Others
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
Single-channel
Dual-channel
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
Hospitals
Ambulatory Surgical Centers
Neurology Clinics
Research Centers
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
288 Pages
- 1. Cardiac Troponin Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
- 2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Cardiac Troponin Market Snippet by Product Type
- 2.1.2. Cardiac Troponin Market Snippet by Test Type
- 2.1.3. Cardiac Troponin Market Snippet by End-user
- 2.1.4. Cardiac Troponin Market Snippet by Country
- 2.1.5. Cardiac Troponin Market Snippet by Region
- 2.2. Competitive Insights
- 3. Cardiac Troponin Key Market Trends
- 3.1. Cardiac Troponin Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Cardiac Troponin Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Cardiac Troponin Market Opportunities
- 3.4. Cardiac Troponin Market Future Trends
- 4. Cardiac Troponin Industry Study
- 4.1. PEST Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
- 5. Cardiac Troponin Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
- 6. Cardiac Troponin Market Landscape
- 6.1. Cardiac Troponin Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players’ Analysis
- 6.2.2. Emerging Players’ Analysis
- 7. Cardiac Troponin Market – By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. High-Sensitivity Cardiac Troponin Tests
- 7.1.3. Conventional Cardiac Troponin Tests
- 7.1.4. Point-of-Care Troponin Tests
- 8. Cardiac Troponin Market – By Test Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
- 8.1.2. Troponin I
- 8.1.3. Troponin T
- 9. Cardiac Troponin Market – By End-user
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
- 9.1.2. Hospitals & Emergency Departments
- 9.1.3. Diagnostic & Clinical Laboratories
- 9.1.4. Ambulatory Surgical Centers
- 9.1.5. Others
- 10. Cardiac Troponin Market– By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Cardiac Troponin Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Cardiac Troponin Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.8. UK
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.8.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.9. France
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.9.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.10.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
- 10.3.11.1. Overview
- 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.11.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
- 10.3.12.1. Overview
- 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.12.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Overview
- 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
- 10.3.14.1. Overview
- 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.14.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
- 10.3.16.1. Overview
- 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.16.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Cardiac Troponin Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.7. China
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.7.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.8. India
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.8.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.12.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.13.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Cardiac Troponin Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Cardiac Troponin Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.8.4. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11. Key Vendor Analysis- Cardiac Troponin Industry
- 11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
- 11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Roche Diagnostics
- 11.2.3. Siemens Healthineers
- 11.2.4. Beckman Coulter
- 11.2.5. bioMérieux
- 11.2.6. Thermo Fisher Scientific
- 11.2.7. QuidelOrtho
- 11.2.8. Becton Dickinson
- 11.2.9. Sysmex Corporation
- 11.2.10. PerkinElmer
- 11.2.11. Bio-Rad Laboratories
- 11.2.12. Fujirebio
- 11.2.13. DiaSorin
- 11.2.14. Randox Laboratories
- 11.2.15. Tosoh Corporation
- 11.2.16. Ortho Clinical Diagnostics
- 11.2.17. Merck KGaA
- 11.2.18. ELITechGroup
- 11.2.19. Getein Biotech
- 11.2.20. Response Biomedical
- 12. 360 Degree AnalystView
- 13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
